Summit’s Client, Seelos Therapeutics, Moves Forward in a Clinical Study of a Novel Ketamine Nasal Spray Medicine for Patients with Depression.

Jul 6, 2021

Altimmune Partners with Summit Biosciences to Produce a Multidose Nasal Spray Presentation of its AdCOVID™ Vaccine Candidate

Mar 22, 2021

Summit Biosciences Donating Even More PPE for COVID-19 Relief

Dec 11, 2020

Summit Biosciences is Featured in Kentucky Governor's Daily COVID-19 Update

Sep 29, 2020

Summit Biosciences Jobs Creation Press Release with Kentucky Governor's Office

Sep 29, 2020

Summit Announces a Client Partnership with Opiant

Jul 22, 2020

Atossa Therapeutics Announces a Contract with Summit Biosciences to Develop a New Treatment for Covid-19

May 28, 2020

Summit Biosciences Donating PPE During COVID-19 Pandemic

Apr 14, 2020

Summit Biosciences Implements Finished Product Serialization

Nov 28, 2018

Summit Biosciences Receives EU Approval for Commercial Manufacturing of Prescription Nasal Sprays

Sep 14, 2017

• 1
• 2
• Next »